We next compared the expression level of the gene signature of PRLR/TGFβRI/TGFβRII generated above in relation to estrogen receptor (ER) expression, as well as in relation to the different breast cancer molecular subtypes using clinical cases available from the GOBO database. This evidence concerns the gene ESR1 and breast carcinoma.